Selecting Systemic Cancer Therapy One Patient at a Time: Is There a Role for Molecular Profiling of Individual Patients With Advanced Solid Tumors?

被引：33

作者：

Doroshow, James H. ^{[1
]}

机构：

[1] NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 33期

关键词：

CLINICAL-TRIAL DESIGN; ANTICANCER AGENTS; BIOMARKERS; CHEMOTHERAPY; BIOPSIES; IMPACT;

D O I：

10.1200/JCO.2010.31.1472

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：4869 / 4871

页数：3

共 33 条

[1]

Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents [J].

Agulnik, Mark ;

Oza, Amit M. ;

Pond, Gregory R. ;

Siu, Lillian L. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (30) :4801-4807

[2]

BURNS CP, 1972, CANCER CHEMOTH REP 1, V56, P527

[3]

The role of salvage treatment in advanced colorectal cancer [J].

Capdevila, Jaume ;

Javier Ramos, Francisco ;

Macarulla, Teresa ;

Elez, Elena ;

Tabernero, Josep .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 71 (01) :53-61

[4]

Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development? [J].

Carden, Craig P. ;

Sarker, Debashis ;

Postel-Vinay, Sophie ;

Yap, Timothy A. ;

Attard, Gerthardt ;

Banerji, Udai ;

Garrett, Michelle D. ;

Thomas, George V. ;

Workman, Paul ;

Kaye, Stan B. ;

de Bono, Johann S. .

DRUG DISCOVERY TODAY, 2010, 15 (3-4) :88-97

[5]

The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer [J].

Chang, Myung Hee ;

Ahn, Jin Seok ;

Lee, Jeeyun ;

Kim, Kyoung Ha ;

Park, Yeon Hee ;

Han, Joungho ;

Ahn, Myung-Ju ;

Park, Keunchil .

LUNG CANCER, 2010, 69 (03) :323-329

[6]

Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents [J].

Dancey, Janet E. ;

Dobbin, Kevin K. ;

Groshen, Susan ;

Jessup, J. Milburn ;

Hruszkewycz, Andrew H. ;

Koehler, Maria ;

Parchment, Ralph ;

Ratain, Mark J. ;

Shankar, Lalitha K. ;

Stadler, Walter M. ;

True, Lawrence D. ;

Gravell, Amy ;

Grever, Michael R. .

CLINICAL CANCER RESEARCH, 2010, 16 (06) :1745-1755

[7]

Dowlati A, 2001, CLIN CANCER RES, V7, P2971

[8]

Biomarkers of Antiangiogenic Therapy: How Do We Move From Candidate Biomarkers to Valid Biomarkers [J].

Duda, Dan G. ;

Ancukiewicz, Marek ;

Jain, Rakesh K. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) :183-185

[9]

Impact of chemotherapy beyond the first line in patients with metastatic breast cancer [J].

Dufresne, Armelle ;

Pivot, Xavier ;

Tournigand, Christophe ;

Facchini, Thomas ;

Altweegg, Thierry ;

Chaigneau, Loic ;

De Gramont, Aimery .

BREAST CANCER RESEARCH AND TREATMENT, 2008, 107 (02) :275-279

[10]

FREI E, 1972, CANCER RES, V32, P2593

← 1 2 3 4 →